ARTICLE | Company News
Soligenix, Hawaii Bio, University of Hawaii deal
June 15, 2015 7:00 AM UTC
Soligenix partnered with the university and Hawaii Biotech to develop a heat-stable subunit Ebola vaccine. Soligenix will use its ThermoVax thermostabilization technology to stabilize components of an Ebola vaccine co-developed by university and Hawaii Biotech. The vaccine has shown efficacy in non-human primates. The companies declined to disclose financial terms. ...